Who invested in Abgentis?
One investor is on record as having backed Abgentis — Developing broad-spectrum antibacterial to treat drug-resistant infections, in Biotech. Each row below says whether the round came from the investor's own portfolio page or from the press.
Abgentis investors
No round dates are on record for Abgentis. A portfolio page names its companies far more often than it dates the cheque, and we would rather leave the field empty than guess it.
The funds that backed Abgentis are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.